Substituted biaryl amides of Formula I are provided. Such compounds are ligands that may be used to modulate C5a receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological C5a receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using them to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
1
提供了公式I的取代
联苯酰胺。这些化合物是
配体,可用于调节C5a受体在体内或体外的活性,并且在治疗与人类、家畜伴侣动物和牲畜动物的病理性C5a受体激活相关的疾病方面特别有用。还提供了用于治疗此类疾病的制药组合物和方法,以及用于受体定位研究的这种
配体的使用方法。